StockData
Evommune, Inc. logo

Evommune, Inc. (EVMN) stock

EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.63−0.39 (-4.86%)

Close on Nov 13, 2026Market cap $276.91MP/E –Yield –

Evommune price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Evommune's price to book ratio was 1.1× on Nov 11, 2026.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×–

More Evommune figures

See a number that looks wrong?